Antenatal Depression, Depression, Depression, Postpartum, Pregnancy Related
Conditions
Brief summary
The purpose of this investigation is to conduct a randomized trial comparing a web-based Mindful Mood Balance for Moms course without coaching support to waitlist control among pregnant or early parenting women with depression histories.
Detailed description
Mindfulness-based cognitive therapy (MBCT) prevents depressive relapse and reduces residual depression symptoms among adults with recurrent depression not currently in episode. Women in perinatal or early parenting years constitute a significant portion of this at-risk population with a history of depression for whom MBCT was designed. Novel delivery formats that provide access to core knowledge and skills of MBCT could increase public health impact-particularly for perinatal or early parenting women-but it is unclear whether such formats have comparable mental health outcomes and changes in putative targets as in-person MBCT. In the present study, we planned to randomize 60 pregnant or early parenting women with a history of major depression and current residual depressive symptoms to MMB for Moms, a web-based course that teaches skills from MBCT customized specifically for pregnant and postpartum women, or waitlist control. We planned to address the following specific aims: Aim 1. We evaluated the extent to MMB for Moms was associated with significant reduction in residual depression symptoms as compared to WLC. We predicted the rate of change in depression symptoms across the study would be greater on average for participants randomized to MMB for Moms relative to those randomized to WLC. Aim 2. We evaluated the extent to MMB for Moms significantly engaged the putative target of decentering as compared to WLC. We predicted the rate of change in decentering across the study would be greater on average for participants randomized to MMB for Moms relative to participants randomized to WLC. Aim 3. We evaluated the extent to MMB for Moms significantly engaged the putative target of self-compassion as compared to WLC. We predicted the rate of change in self-compassion across the study would be greater on average for participants randomized to MMB for Moms relative to participants randomized to WLC.
Interventions
BEHAVIORALMMB for Moms
12-week program that emphasizes mindfulness and cognitive behavioral skills
Sponsors
University of Colorado, Boulder
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. female, 2. pregnant or having had a child within the past 36 months, \* 3. 18 years of age or older, 4. having a history of one or more prior major depressive episode (as assessed by a single question, Have you had a history of mood concerns or major depression?) 5. a current PHQ-9 score of \<= 14, and 6. endorses ability to read and write fluently in English.
Exclusion criteria
1. meeting criteria for current moderately severe depression symptoms (as assessed by the PHQ-9 \>= 15), 2. current imminent suicidality (as assessed by the PHQ-9), and 3. indication of other disorders or symptoms that necessitate priority treatment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of change in depression symptoms | Through 6-month follow-up | Change in the severity of depressive symptoms will be evaluated by the Patient Health Questionnaire-9 (PHQ-9) |
| Rate of change in decentering | Through 6-month follow-up | Change in decentering will be evaluated by the Experiences Questionnaire-Decentering subscale |
| Rate of change in self-compassion | Through 6-month follow-up | Change in self-compassion will be evaluated by the Self-Compassion Scale (SCS) |
| Depressive Relapse Status | Through 6-month follow-up | Rate of depressive relapse will be assessed using the Lifetime Depression Assessment Self-report (LIDAS), adapted to reference the past 3 or 6 months based on survey completion. |
| Rate of change in anxiety symptoms | Through 6-month follow-up | Change in the severity of anxiety symptoms will be evaluated by the 3. Generalized Anxiety Disorder-7 (GAD-7) |
Countries
United States
Outcome results
None listed